Alcoholic Liver Disease

Alcoholic liver disease (ALD) is a spectrum of alcohol-driven hepatic disorders that range from steatosis, hepatitis, fibrosis, and ultimately cirrhosis. Alcoholic hepatitis (AH) is a severe form of acute liver inflammation that causes tissue damage and cell death.  It is associated with high rates of short-term mortality.

DiaPharma offers a variety ELISA assays for measuring blood-based biomarkers in liver research studies. Measuring these biomarkers provides a non-invasive testing approach in the evaluation of liver function and disease mechanisms. Non-invasive testing methods are often used as more accessible alternatives to the standard liver biopsy in research settings. These biomarkers are currently being investigated for use in ALD and AH research and clinical trials to further understand the pathogenesis of alcohol-driven liver diseases and liver responses to ALD therapies.  Read more details…